KOAG Receives FDA Clearance for Vascette® HP Hemostatic Pad for Vascular Closure

25 August 2022 | Thursday | News


KOAG LLC, a Minneapolis-based medical device firm engaged in the design of innovative, topical vascular closure systems, announced today it received FDA clearance for its Vascette® HP device.
Image Source : Public Domain

Image Source : Public Domain

Vascette® is a unique, topical closure pad incorporating a proprietary, plant-derived hemostatic foam. The Vascette® patent-pending technology supports rapid hemostasis (blood stoppage) after cardiac catheterization without direct compression over the arterial puncture site (arteriotomy). 

KOAG will exhibit the Vascette® HP at the Association for Vascular Access (AVA) congress in MinneapolisSeptember 30-Oct 2.

KOAG LLC is a privately held medical device organization headquartered in suburban Minneapolis, MN.

News

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close